Skip to content
healthcare.dev
Get a free key

CAPTOPRIL AND HYDROCHLOROTHIAZIDE

NDC 16571-829, CAPTOPRIL AND HYDROCHLOROTHIAZIDE, tablet, from Rising Pharma Holdings, Inc..

Product NDC
16571-829
Status
Listed
Labeler
Rising Pharma Holdings, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074896
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/16571-829 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CAPTOPRIL50 mg/1
  • HYDROCHLOROTHIAZIDE15 mg/1

Pharmacologic classes

Angiotensin Converting Enzyme Inhibitor [EPC]; Angiotensin-converting Enzyme Inhibitors [MoA]; Increased Diuresis [PE]; Thiazide Diuretic [EPC]; Thiazides [CS]

Package NDCNDC-11Package
16571-829-091657108290990 TABLET in 1 BOTTLE (16571-829-09)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0ea90fd4-0da6-4ad2-ab83-6cfbe0ae515e

Use it

Look up 16571-829 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/16571-829 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 16571-829. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.